fenyramidol
{{Short description|Muscle relaxant drug}}
{{Drugbox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 376112914
| IUPAC_name = 1-phenyl-2-(pyridin-2-ylamino)ethanol
| image = phenyramidol.png
| tradename = Cabral
| Drugs.com = {{drugs.com|international|fenyramidol}}
| pregnancy_AU =
| pregnancy_US =
| pregnancy_category =
| legal_AU =
| legal_CA =
| legal_UK =
| legal_US =
| legal_status =
| routes_of_administration =
| bioavailability =
| protein_bound =
| metabolism =
| elimination_half-life =
| excretion =
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 553-69-5
| ATC_prefix = M03
| ATC_suffix = BX30
| PubChem = 9470
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank =
| UNII_Ref = {{fdacite|changed|FDA}}
| UNII = R3V02WL7O3
| ChEMBL_Ref = {{ebicite|changed|EBI}}
| ChEMBL = 1697767
| ChemSpiderID = 9098
| C=13 | H=14 | N=2 | O=1
| smiles = C1=CC=CC(=C1)C(CNC2=NC=CC=C2)O
| StdInChI = 1S/C13H14N2O/c16-12(11-6-2-1-3-7-11)10-15-13-8-4-5-9-14-13/h1-9,12,16H,10H2,(H,14,15)
| StdInChIKey = ZEAJXCPGHPJVNP-UHFFFAOYSA-N
}}
Fenyramidol (INN) or phenyramidol (BAN, USAN), trade name Cabral, is a pharmaceutical drug which acts as a muscle relaxant.{{cite journal | vauthors = O'Dell TB | title = Pharmacology of phenyramidol (IN511) with emphasis on analgesic and muscle-relaxant effects | journal = Annals of the New York Academy of Sciences | volume = 86 | pages = 191–202 | date = March 1960 | issue = 1 | pmid = 14428054 | doi = 10.1111/j.1749-6632.1960.tb42799.x | bibcode = 1960NYASA..86..191O }}
Drug Interactions
Fenyramidol inhibits the metabolism of phenytoin, leading to possible increases in plasma phenytoin levels.{{Cite book |last=Patsalos |first=P. N. |title=Antiepileptic drug interactions : a clinical guide |date=2013 |publisher=Springer |isbn=978-1-4471-2434-4 |edition=2nd |location=London |pages=245 |oclc=820958181}}
References
{{reflist}}
{{Muscle relaxants}}
Category:Drugs with unknown mechanisms of action
{{musculoskeletal-drug-stub}}